Amanda Louise Murphy - 12 Nov 2021 Form 4 Insider Report for MAXCYTE, INC. (MXCT)

Role
Chief Financial Officer
Signature
/s/ Brian F. Leaf, attorney-in-fact
Issuer symbol
MXCT
Transactions as of
12 Nov 2021
Net transactions value
-$1,183,567
Form type
4
Filing time
16 Nov 2021, 18:12:00 UTC
Previous filing
11 Aug 2021
Next filing
29 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MXCT Common Stock Options Exercise $225,875 +51,103 $4.42 51,103 12 Nov 2021 Direct F1
transaction MXCT Common Stock Sale $646,964 -51,103 -100% $12.66 0 12 Nov 2021 Direct F2
transaction MXCT Common Stock Options Exercise $272,232 +61,591 $4.42 61,591 15 Nov 2021 Direct F1
transaction MXCT Common Stock Sale $748,947 -61,591 -100% $12.16 0 15 Nov 2021 Direct F3
transaction MXCT Common Stock Options Exercise $164,893 +37,306 $4.42 37,306 16 Nov 2021 Direct F1
transaction MXCT Common Stock Sale $450,656 -37,306 -100% $12.08 0 16 Nov 2021 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -51,103 -4.4% $0.000000 1,098,897 12 Nov 2021 Common Stock 51,103 $4.42 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -61,591 -5.6% $0.000000 1,037,306 15 Nov 2021 Common Stock 61,591 $4.42 Direct F1, F5
transaction MXCT Employee Stock Option (right to buy) Options Exercise $0 -37,306 -3.6% $0.000000 1,000,000 16 Nov 2021 Common Stock 37,306 $4.42 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise price is in U.S. Dollars and reflects the conversion of GBP to USD at an exchange rate of GBP 1.00 to $1.34.
F2 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.56 to $12.765, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F3 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.03 to $12.615, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F4 The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
F5 One-sixteenth (1/16th) of the shares underlying this option vested on December 7, 2020, and the remainder vested or shall vest monthly in forty-five (45) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date.